cro.directory
← Compare landing

Ace Therapeutics vs Cyagen Biosciences

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAce TherapeuticsCyagen Biosciences
SummaryPreclinical CRO providing integrated research services including efficacy testing, disease model development, PK/PD, toxicology, biomarker research, and safety assessment across respiratory, ophthalmology, cardiovascular, and neurology therapeutic areas.Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.
ServicesData not yet provided.
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Translational Research
  • Virology Services
  • Immunology & Inflammation Services
ModalitiesData not yet provided.
  • Biologics (Monoclonal Antibodies)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Neurology
  • Psychiatry
  • Cardiovascular
  • Respiratory
  • Ophthalmology
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Ophthalmology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
LocationsData not yet provided.
  • Headquarters, Santa Clara, California, United States
CertificationsData not yet provided.
  • AAALAC International · Identifier: AAALAC-accredited facilities

Find similar companies

Ace Therapeutics alternatives · Cyagen Biosciences alternatives

Markdown mirror: /compare/ace-therapeutics/cyagen.md